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Lastyear,therewasagreatdealofattentiondevotedto
lymphnodestatusandthestagingofcoloncancer.This
culminated in the National Quality Forum endorsing
the 12-node minimum as a proxy measure of quality
andnecessaryforadequatestaging.This,however,has
been criticized as an oversimpliﬁcation because it is
unclear whether lymph node evaluation is inﬂuenced
by the surgeon, the pathologist, or even the patient.
With more eﬀective and expensive chemotherapeutic
andbiologicagentsavailableforthetreatmentofcolon
cancer, there is a need to develop better staging meth-
ods to improve the selection of patients for therapy.
Even in node-negative patients, the use of adjuvant
chemotherapyisadvocatedbytheAmericanSocietyof
Clinical Oncology solely on the basis of the low lymph
node collection. Rather than number of lymph nodes
alone as a prognostic factor, some have proposed
lymphnoderatio(LNR)alsoasanimportantmeasure.
Wang et al.
1 report a retrospective study of data
from the National Cancer Institute’s Surveillance
Epidemiology and End Results Program. They
identiﬁed 24,477 patients with stage III colon cancer
and examined the role of LNR in staging and prog-
nosis. LNR, deﬁned as the number of positive lymph
nodes divided by the total number of lymph nodes
examined, was an independent predictor for survival,
which could be used to stratify patients with stage
IIIB and IIIC colon cancer. Ratio groups LNR1
through LNR4 were deﬁned as\1/14, 1/14 to 25%,
25% to 50%, and 50% to 100%, respectively. This
study conﬁrms the prognostic implications of LNR
suggested in smaller retrospective studies
2 and com-
plements the reported correlation between more
extensive nodal dissection and improved survival of
patients with colon cancer.
3
Although the tumor status of regional lymph nodes
is essential for staging of colon cancer, the impor-
tance of the total number of collected lymph nodes
remains controversial. A more extensive lymph node
dissection was thought to increase survival only by
increasing the likelihood of upstaging disease (i.e.,
higher likelihood of ﬁnding a disease-positive node
when more lymph nodes are examined). However,
further investigations have shown a direct correlation
between number of collected nodes and clinical out-
come within speciﬁc stages of disease.
4 The reason for
this difference in survival is still debatable. Interest-
ingly, in the review by Wang et al.,
1 the prognostic
signiﬁcance of LNR was not dependent on the
number of collected nodes. Of 9610 patients who had
fewer than 10 lymph nodes examined, the survival
difference between LNR2 (N = 2888) and LNR4
(N = 3734) was 22.4% (P\.0001).
Given the increased emphasis on implementing
quality measures and documenting outcomes, the
number of collected nodes is likely to become a factor
in determining the quality of surgical procedures for
colon cancer. Still, although the importance of an
adequate lymphadenectomy by the surgeon cannot be
overstated, it would be premature to propose ade-
quacy of nodal resection as a quality indicator or
criterion for reimbursement by insurance companies.
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1557As noted by Wang’s group,
1 the number of posi-
tive/total nodes also depends on the pathologist and
the methods used to identify metastases in resected
lymph nodes (i.e., hematoxylin and eosin staining,
immunohistochemistry, or polymerase chain reac-
tion). We have previously reported a marked increase
in the detection of metastases by using sentinel node
techniques in colon cancer.
5 Collaboration between
surgeon and pathologist is essential to ensure com-
plete specimen evaluation.
Because LNR combines information on the number
of disease-positive lymph nodes and the total number
of resected nodes, both of which have independent
prognostic signiﬁcance, it merits further investigation
as a possible standard tool for staging colon cancer.
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